Global Prescription Digital Therapeutics (PDTx) Market is expected to grow with the CAGR of 21.6% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-prescription-digital-therapeutics-dtx-market

Global prescription digital therapeutics (PDTx) market is a highly consolidated market which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.    

The major players dealing in global prescription digital therapeutics (PDTx) market are introducing strong range of products provider along with launching new products and adopting strategic initiatives such as acquisition and agreement into the prescription digital therapeutics (PDTx) market. This helped companies to maximize the sales with enhanced product portfolio. For instance, in September 2020, Pear Therapeutics, Inc. announces the availability of RESET AND RESET-O to the Wellpath Community Care Center Patients for the treatment of addiction disorders.  

Omada Health, Inc. is the dominating player in global prescription digital therapeutics (PDTx) market. The other key players existing in the prescription digital therapeutics (PDTx) market includes ResMed, SAMSUNG, GAIA AG, Pear Therapeutics, Inc., Welldoc’s Bluestar, Solera Network, Akili Interactive Labs, Inc., Better Therapeutics, LLC, BigHealth, Biofourmis, Click Therapeutics, Inc., Happify, Inc., Limbix Health, Inc., Naturalcycles Nordic AB, NuvoAir AB, Sensyne Health plc, Voluntis and Xealth.

Omada Health, Inc.

Omada Health, Inc. is headquartered in California, U.S. The company is focused on bringing the human connection to digital care by inspiring and engaging people in lifelong health, one step at a time. The company provides product named as omada.

For instance,

• In September 2020, Omada Health, Inc. received positive result from the clinical study of Omada intended for treatment of diabetes. The result obtained suggested that the Omada has been proved to be successful in reducing the level of haemoglobin A1c by 0.8 percent. The study demonstrated the effectiveness of product and hence enhanced the product values in the

For instance,

• diabetes treatment market using digital therapy.

The company has presence across North America.

ResMed

ResMed is headquartered in California, U.S. and was founded in 1989. The company is focused on building global innovation in sleep and respiratory care in order to improve the 250 million lives without the out-of-hospital care. The company deals in various segments such as sleep and respiratory care and software as a service out of which sleep and respiratory care is the market focused segment. The company provides products under categories such as masks, devices, software solutions and more among which software solutions is the market focused category.

For instance,

• In October 2019, ResMed announced that most of the people prefer digital therapeutics for improving the health outcomes. The company suggested that out of the 3,000 people, 56% are adopting for digital data tools in order to manage their health. The study also suggested that 10 million cloud- connectable sleep apnea and respiratory care devices are available at patients home. Moreover, the news also suggested that 87% of people using sleep apnea devices are adherent on digital therapy. This news thus suggested that people in America are extensively using digital therapy.

The company has wide presence across Africa, Middle East, Americas, Asia-Pacific and Europe.

SAMSUNG

SAMSUNG is headquartered in Seoul, Republic of Korea and was founded in 1969. The company is focused on the research and development of electronics, mobile and IT services in order to create new values and improve people's lives. The company deals in various segments such as CE, IM, DS and harman out of which IM is the market focused segment. The company provides products under categories such as artificial intelligence, data intelligence, next generation communications and robot among which artificial intelligence is the market focused category.

For instance,

• In May 2020, SAMSUNG, the parent company of HARMAN International collaborated with the F. Hoffman-La Roche Ltd to create a digital therapeutics platform in order to treat autism spectrum disorder. This partnership allowed the company to develop the advanced digital behavioural therapy which can improve the health outcome of patients facing autism problem. This initiative thus paved the way for the company to expand its root in prescription digital therapeutics (PDTx) market.  

The company has wide presence across Americas, Europe, Middle East and Africa and Asia-Pacific. The company has various subsidiaries such as Samsung Electronics America Inc. (SEA) (U.S.), Dacor Canada Co. (Canada), Samsung Mexicana S.A. de C.V (SAMEX) (Mexico), Samsung Electronics Mexico S.A. De C.V. (SEM) (Mexico), Samsung Electronics Canada, Inc. (SECA) (Canada) among others.